Fibroblast growth factor 1 gene-transfected adipose-derived mesenchymal stem cells modulate ...
Conclusion: These data suggest that the administration of AD-MSCs FGF1 through modulating apoptosis and neuroinflammation could be considered as a promising medicine for the treatment of neuropathic pain.
Source: Iranian Journal of Pharmaceutical Research - Category: Drugs & Pharmacology Source Type: research
More News: Back Pain | Brain | Chronic Pain | Drugs & Pharmacology | Genetics | Iran Health | Neurology | Pain | Spinal Cord Injury | Stem Cell Therapy | Stem Cells | Study